Genetic research has identified changes in specific genes which cause neurological disorders. As a result, DNA-based diagnostic tests have been developed to detect these changes, which may enable the accurate and definitive diagnosis of many conditions.

There is increasing evidence that genetic changes can have a direct impact on the choice and effectiveness of some drug therapies. An accurate DNA-based diagnosis of patients with neurogenetic disorders can therefore enhance the management of their condition.

Genetic Technologies offers neurogenetic diagnostic assays encompassing: